Fasheng Li, Xinmei Shao, Dehui Liu, Xiaogang Jiao, Xinqi Yang, Wencai Yang, & Xiaoyan Liu. (2022). Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance. MDPI AG.
Chicago Style (17th ed.) CitationFasheng Li, Xinmei Shao, Dehui Liu, Xiaogang Jiao, Xinqi Yang, Wencai Yang, and Xiaoyan Liu. Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis Through Alleviation of Immune Surveillance. MDPI AG, 2022.
MLA (9th ed.) CitationFasheng Li, et al. Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis Through Alleviation of Immune Surveillance. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.